Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.

Abstract

Oxidative stress has been implicated in the pathogenesis of hyperthyroidism and its complications. Interaction of advanced glycation end products (AGEs) with receptor RAGE (receptor for AGEs) generates reactive oxygen species. Soluble receptor for AGEs (sRAGE) competes with RAGE for binding with AGEs and attenuates the generation of ROS. Low levels sRAGE and high levels AGEs would generate more ROS leading to hyperthyroidism and its complications. The objectives are to determine if levels of serum sRAGE are low and the levels of AGEs and AGEs/sRAGE are high in patients with hyperthyroidism. The study subjects comprised of 33 patients with hyperthyroidism and 20 controls. Levels of serum sRAGE were lower, while that of AGEs and AGEs/sRAGE were higher in patients compared to controls, being significant only for sRAGE and AGEs/sRAGE. When the levels of sRAGE, AGEs, and AGEs/sRAGE were assessed for hyperthyroidism associated with different diseases, the levels of sRAGE were lower in Hashimoto disease, and levels of AGEs were higher in patients with Graves' disease compared to control. The levels of AGEs/sRAGE were elevated in an all except patients with Hashimoto disease. The levels of AGEs, sRAGE, or AGEs/RAGE were not correlated with age, weight, and blood pressures except systolic pressure which was inversely correlated with sRAGE. The levels of sRAGE were negatively correlated with AGEs and AGEs/sRAGE. The levels of AGEs/sRAGE were positively correlated with AGEs. In conclusion, low levels of sRAGE, and high levels of AGEs and AGEs/sRAGE are risk biomarkers in the pathogenesis hyperthyroidism and its complications.

• Authors: Gudrun Caspar-Bell, Indu Dhar, Kailash Prasad
• Journal: Molecular and cellular biochemistry (Mol Cell Biochem) Vol. 414 Issue 1-2 Pg. 171-8 (Mar 2016) ISSN: 1573-4919 [Electronic] Netherlands
• PMID: 26895319 (Publication Type: Journal Article)

Chemical References

• Biomarkers
• Glycation End Products, Advanced
• Receptor for Advanced Glycation End Products

Topics

• Adult
• Biomarkers (metabolism)
• Female
• Glycation End Products, Advanced (blood)
• Humans
• Hyperthyroidism (physiopathology)
• Male
• Receptor for Advanced Glycation End Products (blood)